Sundrug Co.,Ltd. (TSE:9989) agreed to acquire Daiya, K.K. from Shintaro Ito, Ichiban Co., Ltd and others on September 1, 2022. For the period ended February 2022, Daiya reported Total assets of 12 billion, net worth of 2.5 billion, Revenue of 26.6 billion, Operating income of 216 million, and Net income of 418 million. The acquisition is expected to close on October 3, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,528 JPY | +0.13% | +3.50% | -0.09% |
2023 | Harris Associates says cautious on Japan, all in on Europe | RE |
2023 | Consolidation to boost value of Japan's still fragmented drugstore sector - Orbis | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.09% | 3.4B | |
-11.64% | 3.7B | |
-23.44% | 3.07B | |
+7.56% | 2.72B | |
+6.72% | 2.58B | |
-9.26% | 1.74B | |
+9.30% | 1.38B | |
-20.60% | 958M | |
-38.62% | 702M | |
-0.53% | 449M |
- Stock Market
- Equities
- 9989 Stock
- News Sundrug Co.,Ltd.
- Sundrug Co.,Ltd. agreed to acquire Daiya, K.K. from Shintaro Ito, Ichiban Co., Ltd and others.